Back to Top Skip to main content Skip to sub-navigation

Janssen COVID-19 vaccine returns to Military Health System

Image of Military personnel wearing a face mask and a face shield administering the COVID-19 vaccine. Navy Hospitalman Jared Houchen, Combined Arms Training Center Camp Fuji Branch Health Annex, Gotenba, Shizuoka, Japan, administers the Janssen COVID-19 vaccine to a Marine at the installation March 16. CATC Camp Fuji, which sees a high number of transient training units, was the first installation in Japan to administer the single-dose vaccine (Photo by: Katie Gray, Marine Corps Installations Pacific).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Doses of the Janssen COVID-19 vaccine are now available to those in the Military Health System eligible and authorized to receive COVID-19 vaccinations, said Air Force Col. Jennifer Garrison, DoD COVID-19 Vaccine Program Operation Team Lead for the Department of Defense.

The Food and Drug Administration and the Centers for Disease Control and Prevention gave the greenlight to resuming use of the Janssen (also called Johnson & Johnson) vaccine April 23.

Aligning to the CDC, the MHS plan was subsequently approved by the White House and the CDC, Garrison said.

Defense Health Agency Director Army Lt. Gen. (Dr.) Ronald Place said: "We have full confidence that the J&J vaccine is safe and effective in preventing COVID-19 and that the data shows the vaccine's known potential benefits outweigh its known and potential risks."

The vaccine received FDA emergency use authorization Feb. 27 and was put on pause by the FDA and the CDC April 13 due to a small instance of those vaccinated with the Janssen product developing a rare, but serious blood clotting disorder that has now been named Thrombosis with Thrombocytopenia Syndrome (TTS).

TTS occurred at a rate of about 7 per 1 million vaccinated women between the ages of 18 and 49. For women 50 and older and men of all ages, this adverse event is even more rare.

FDA has added a warning to the Janssen COVID-19 vaccine emergency use authorization and fact sheets regarding the clotting events, CDC said. As of April 23, TTS had not been linked to the Pfizer-BioNTech or Moderna vaccines.

As of April 21, approximately 7.98 million doses of the Janssen COVID-19 vaccine had been administered in the United States, the CDC said in a report released April 27.

More than 2.62 million doses of the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines have been given to those eligible and authorized within the Military Health System (MHS), and more than 438,000 have been administered to MHS beneficiaries at retail pharmacies and other non-DOD sites, Place explained during a news conference April 21.

The Janssen vaccine makes up less than 3% of the doses provided to the Department of Defense, according to the DOD.

So far, Place said, there have been no cases reported in the military of the blood clotting serious adverse event, but data are being reviewed.

Out of an abundance of caution, CDC said it would review the Janssen data through its Advisory Committee on Immunization Practices (ACIP). The committee met April 14 and decided to keep the pause in vaccinations in place while it further reviewed the data from the Janssen large-scale clinical trials and the adverse events. On April 23, the ACIP recommended the restart of Janssen vaccinations.

A review of all available data shows that the one-shot Janssen COVID-19 vaccine's "known and potential benefits outweigh its known and potential risks for those recommended to receive it," the CDC announced April 25.

However, "women younger than 50 years old should be aware of the rare but increased risk of the TTS adverse event, and that there are other COVID-19 vaccine options available for which this risk has not been seen," CDC said.

People who have received the Janssen vaccine who develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider, the CDC said.

The pause allowed the CDC to re-emphasize with health care providers the importance of reporting severe events in people who have received this vaccine, as well as how to report such events. The pause also gave experts time to carefully review all available data and conduct a risk-benefit analysis of the vaccine.

Military vaccination sites have continued local planning and messaging for reintroduction of the Janssen vaccine. Any products or processes that need to be changed based on the CDC's April 27 "Morbidity and Mortality Weekly Report" and its clinicians' briefing will be finalized April 28, Garrison said. The DHA Director's directive to resume vaccinations with any additional guidance or changes required will be produced and published.

The Janssen vaccine is a replication-deficient adenovirus-vectored vaccine like the AstraZeneca/Oxford vaccine, which has not yet received FDA emergency use authorization.

This means it uses a different virus, such as measles or adenovirus, which is genetically engineered so that it can produce coronavirus proteins in the body and trigger the immune system to make antibodies against those proteins.

The viruses used in viral-vector vaccines are weakened or inactivated, so they cannot cause disease or harm humans. Viral-vector vaccines are also relatively fragile and must be maintained at temperatures that allow them to remain intact to work optimally.

The resource center on the Pfizer, Moderna and Janssen vaccines provides a plethora of information for MHS health care professionals.

 

You also may be interested in...

Formulary Search Tool Buckslip: Color

Publication
1/27/2022

A color copy of buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Formulary Search Tool Buckslip: Black and White

Publication
1/27/2022

A set of three, black & white buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

How COVID-19 Vaccines Work

Publication
6/9/2021

Learn how the different COVID-19 vaccines work.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Getting the COVID-19 Vaccine | COVID-19 Vaccine Efforts

COVID-19 Vaccine Leader Card

Publication
5/27/2021

This printable card provides talking points when discussing the COVID-19 vaccine with servicemembers who are reluctant or indifferent to accepting the vaccine. The card lists common concerns and impressions, top 5 key messages, and supporting facts about the vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Provider Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for Military Health System (MHS) providers to discuss the COVID-19 vaccine with servicemembers during routine visits. Initiating a COVID-19 vaccine conversation during servicemember visits will allow you to effectively address concerns, build trust, and boost vaccine confidence.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Unit Leader Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for preparation, delivery, and navigation of small group discussions (recommended 1-5 people to facilitate greatest engagement) with servicemembers reluctant or indifferent to accepting the vaccine. The guide promotes an open dialogue regarding vaccine hesitancy and complacency by addressing concerns, building trust, and boosting vaccine confidence.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

VAX Facts Underlying Conditions

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5
Refine your search
Last Updated: May 04, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.